The identification of specific post-thrombotic complications as well as an increased appreciation of the importance of patient-reported outcome measures have triggered an interest in studying health-related quality of life (HRQoL) in patients with a history of venous thromboembolism (VTE).
In order to enable a comprehensive assessment of HRQoL in clinical trials it is recommended that both generic and disease-specific questionnaires be used. SF-36 and EQ-5D are the most widely used generic questionnaires in VTE studies, whereas several disease-specific questionnaires have been developed to evaluate HRQoL following deep vein thrombosis (DVT) and in chronic venous disease (CVD). The most widely used of these is the VEINES-QOL/Sym, which was developed for CVD. VT-QOL and DVTQOL are both questionnaires developed to evaluate HRQoL after DVT, while PEmb-QoL is currently the only available disease-specific questionnaire developed specifically for pulmonary embolism (PE).
Although studies show inconsistent results, patients who sustain DVT seem in general to report similar HRQoL compared to the general population. However, patients who develop PTS after DVT report poorer HRQoL using both generic and disease-specific questionnaires. HRQoL appears to be impaired in patients who sustain PE compared to the general population. In these patients, persistent dyspnea after PE has been shown to be a predictor of reduced HRQoL.
Further work is needed to develop practical, patient-derived, valid, reliable and responsive disease-specific HRQoL instruments covering the specific aspects of these diseases.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Thrombosis Research
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism.J. Thromb. Haemost. 2012; 10: 507-511
- The post-PE syndrome: a new concept for chronic complications of pulmonary embolism.Blood Rev. 2014; 28: 221-226
- Post-thrombotic syndrome: prevalence, prognostication and need for progress.Br. J. Haematol. 2009; 145: 286-295
- The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.Haematologica. 2007; 92: 199-205
- Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.N. Engl. J. Med. 2004; 350: 2257-2264
- Incidence and cost burden of post-thrombotic syndrome.J. Thromb. Thrombolysis. 2009; 28: 465-476
- 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).Eur. Heart J. 2016; 37: 67-119
- WHOQOL: Measuring Quality of Life.
- Measuring health-related quality of life in venous disease: practical and scientific considerations.Angiology. 1997; 48: 51-57
- Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life.J. Gen. Intern. Med. 2000; 15: 425-429
- Regarding “evaluating outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life”.J. Vasc. Surg. 2003; 37: 911-912
- Why generic and disease-specific quality-of-life instruments should be used together for the evaluation of patients with persistent allergic rhinitis.Clin. Exp. Allergy. 2005; 35: 288-298
- Assessing quality of life in diabetes: I. A practical guide to selecting the best instruments and using them wisely.Diabetes Res. Clin. Pract. 2017; 126: 278-285
- Quality of Life: The Assessment, Analysis and Reporting of Patient-reported Outcomes.3rd ed. Wiley, 2014
- F.a.D. Administration Guidance for Industry Patient-reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009
- Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia.Haematologica. 2014; 99: 788-793
- Guidelines for Developing Questionnaire Modules.http://groups.eortc.be/qol/sites/default/files/archives/guidelines_for_developing_questionnaire-_final.pdfDate: 2011
- Improving the quality of reporting of randomized controlled trials. The CONSORT statement.JAMA. 1996; 276: 637-639
- The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.Qual. Life Res. 2010; 19: 539-549
- Health outcomes in economic evaluation: the QALY and utilities.Br. Med. Bull. 2010; 96: 5-21
- EuroQol—a new facility for the measurement of health-related quality of life.Health Policy. 1990; 16: 199-208
- Danish EQ-5D population norms.Scand. J. Public Health. 2009; 37: 467-474
- Guidline: Patients-reported Outcomes in Hematology.2012
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.Med. Care. 1992; 30: 473-483
- A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity.Med. Care. 1996; 34: 220-233
- Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA project. International Quality of Life Assessment.J. Clin. Epidemiol. 1998; 51: 1171-1178
- Comparison of the short form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease.Heart. 2004; 90: 523-527
- Short-forms Health Survey Questionnaire.
- Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ).Qual. Life Res. 1996; 5: 539-554
- Negative impact of deep venous thrombosis on chronic venous disease.Thromb. Res. 2013; 131: e123-6
- Endovascular stent placement for chronic post-thrombotic symptomatic ilio-femoral venous obstructive lesions: a single-center study of safety, efficacy and quality-of-life improvement.Quant. Imaging Med. Surg. 2016; 6: 342-352
- Psychometric validation of the 14 items ChronIc Venous Insufficiency Quality of Life Questionnaire (CIVIQ-14): confirmatory factor analysis.Eur. J. Vasc. Endovasc. Surg. 2016; 51: 268-274
- An instrument for measuring health-related quality of life in patients with deep venous thrombosis (DVT): development and validation of deep venous thrombosis quality of life (DVTQOL) questionnaire.Health Qual. Life Outcomes. 2004; 2: 30
- A health-related quality of life measure in patients with deep vein thrombosis: a validation study.Drug Inf. J. 1999; 33: 14
- Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life.J. Vasc. Surg. 2003; 37: 410-419
- The impact of venous thrombosis on quality of life.Thromb. Res. 2004; 114: 11-18
- Quality of life after pulmonary embolism: validation of the PEmb-QoL questionnaire.J. Thromb. Haemost. 2010; 8: 523-532
- Quality of life after pulmonary embolism: the development of the PEmb-QoL questionnaire.J. Thromb. Haemost. 2009; 7: 1044-1046
- Quality of life after pulmonary embolism: validation of the French version of the PEmb-QoL questionnaire.Health Qual. Life Outcomes. 2014; 12: 174
- Health-related quality of life after pulmonary embolism: a cross-sectional study.BMJ Open. 2016 Nov 3; 6
- Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life.Ann. Surg. 2004; 239: 118-126
- Prospective evaluation of health-related quality of life in patients with deep venous thrombosis.Arch. Intern. Med. 2005; 165: 1173-1178
- Health-related Quality of Life After Deep Vein Thrombosis.5(1). SpringerPlus, 2016: 1278
- What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis.Thromb. Haemost. 2016; 116: 417-431
- Determinants of health-related quality of life during the 2 years following deep vein thrombosis.J. Thromb. Haemost. 2008; 6: 1105-1112
- The influence of venous thromboembolism on quality of life and severity of chronic venous disease.J. Thromb. Haemost. 2004; 2: 2146-2151
- Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis.J. Vasc. Interv. Radiol. 2012;
- Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity.J. Thromb. Haemost. 2011; 9: 1931-1936
- Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study.BMJ Open. 2013; 3e002984
- Rivaroxaban Versus Warfarin for the Prevention of Post-thrombotic Syndrome.International Society on Thrmbosis and Hemaostasis, Berlin, Germany2017
- Quality of life in long-term survivors of acute pulmonary embolism.Chest. 2010; 138: 1432-1440
- Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: results of a questionnaire.Eur. J. Intern. Med. 2008; 19: 625-629
- Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL.Thromb. Res. 2013; 132: 500-505
- Functional and exercise limitations after a first episode of pulmonary embolism: results of the ELOPE prospective cohort study.Chest. 2016;
- Quality of Life, dyspnea and functional exercise capacity following a first episode of pulmonary embolism: results of the ELOPE cohort study.Am. J. Med. 2017 Aug; 130 (Epub 2017 Apr 8): 990.e9-990.e21https://doi.org/10.1016/j.amjmed.2017.03.033
- Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: systematic review with meta-analysis.Vasc. Med. 2017; 22: 37-43
- Health-related quality of life in a national cohort of patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.Arch. Bronconeumol. 2013; 49: 181-188
- Living with pulmonary hypertension: unique insights from an international ethnographic study.BMJ Open. 2014; 4e004735
- Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.J. Thromb. Haemost. 2014; 12: 459-468
- Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.J. Thromb. Thrombolysis. 2015; 40: 161-166
- Measurement of health status. Ascertaining the minimal clinically important difference.Control. Clin. Trials. 1989; 10: 407-415
- A point of minimal important difference (MID): a critique of terminology and methods.Expert Rev. Pharmacoecon. Outcomes Res. 2011; 11: 171-184
- Quality of life after pulmonary embolism: first cross-cultural evaluation of the pulmonary embolism quality-of-life (PEmb-QoL) questionnaire in a Norwegian cohort.Qual. Life Res. 2015; 24: 417-425
Published online: July 23, 2017
Accepted: July 21, 2017
Received in revised form: July 14, 2017
Received: May 7, 2017
☆This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
© 2017 Elsevier Ltd. All rights reserved.